Part of the Genetics and Genomics Commons
2013
Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis., Toni‐Kim Clarke, Paul J. Bloch, Lisa M. Ambrose‐Lanci, Thomas N. Ferraro, Wade H. Berrettini, Kyle M. Kampman, Charles A. Dackis, Helen M. Pettinati, Charles P. O'Brien, David W. Oslin, Falk W. Lohoff
Thomas Ferraro
Further evidence for association between genetic variants in the cannabinoid receptor 1 (CNR1) gene and cocaine dependence: Confirmation in an independent sample and meta-analysis, Toni-Kim Clarke, Paul J. Bloch, Lisa M. Ambrose-Lanci, Glenn A. Doyle, Thomas N. Ferraro, Wade H. Berrettini, Kyle M. Kampman, Charles A. Dackis, Helen M. Pettinati, Charles P. O’Brien, David W. Oslin, Falk W. Lohoff
Thomas Ferraro
Case-control association study of WLS variants in opioid and cocaine addicted populations, Richard C. Crist, Lisa M. Ambrose-Lanci, Angela Zeng, Cindy Yuan, Kyle M. Kampman, Helen M. Pettinati, David W. Oslin, Charles P. O'Brien, Thomas N. Ferraro, Glenn A. Doyle, Falk W. Lohoff, Wade H. Berrettini
Thomas Ferraro
Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine., Toni-Kim Clarke, Richard C. Crist, Kyle M. Kampman, Charles A. Dackis, Helen M. Pettinati, Charles P. O’Brien, David W. Oslin, Thomas N. Ferraro, Falk W. Lohoff, Wade H. Berrettini
Thomas Ferraro
2010
Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependence, Falk W. Lohoff, Paul J. Bloch, Rachel Hodge, Aleksandra H. Nall, Thomas N. Ferraro, Kyle M. Kampman, Charles A. Dackis, Charles P. O'brien, Helen M. Pettinati, David W. Oslin
Thomas Ferraro
2009
Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence., Falk W. Lohoff, Paul J. Bloch, Thomas N. Ferraro, Wade H. Berrettini, Helen M. Pettinati, Charles A. Dackis, Charles P. O’Brien, Kyle M. Kampman, David W. Oslin
Thomas Ferraro
Association analysis between polymorphisms in the dopamine D3 receptor (DRD3) gene and cocaine dependence, Paul J. Bloch, Aleksandra H. Nall, Andrew E. Weller, Thomas N. Ferraro, Wade H. Berrettini, Kyle M. Kampman, Helen M. Pettinati, Charles A. Dackis, Charles P. O'Brien, David W. Oslin, Falk W. Lohoff
Thomas Ferraro
2008
Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence, Falk W. Lohoff, Paul J. Bloch, Andrew E. Weller, Aleksandra H. Nall, Glenn A. Doyle, Russell J. Buono, Thomas N. Ferraro, Kyle M. Kampman, Helen M. Pettinati, Charles A. Dackis, David W. Oslin, Charles P. O'Brien, Wade H. Berrettini
Russell Buono
Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence, Falk W. Lohoff, Paul J. Bloch, Andrew E. Weller, Aleksandra H. Nall, Glenn A. Doyle, Russell J. Buono, Thomas N. Ferraro, Kyle M. Kampman, Helen M. Pettinati, Charles A. Dackis, David W. Oslin, Charles P. O'Brien, Wade H. Berrettini
Thomas Ferraro
Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence., Falk W. Lohoff, Andrew E. Weller, Paul J. Bloch, Aleksandra H. Nall, Thomas N. Ferraro, Kyle M. Kampman, Helen M. Pettinati, David W. Oslin, Charles A. Dackis, Charles P. O'Brien, Wade H. Berrettini
Thomas Ferraro
2006
Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine dependence, John P. Dahl, Joseph F. Cubells, Riju Ray, Andrew E. Weller, Falk W. Lohoff, Thomas N. Ferraro, David W. Oslin, Kyle M. Kampman, Charles Dackis, Yilang Tang, Joel Gelernter, Henry R. Kranzler, Charles P. O'brien, Wade H. Berrettini
Thomas Ferraro
2005
Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependence., John P. Dahl, Andrew E. Weller, Kyle M. Kampman, David W. Oslin, Falk W. Lohoff, Thomas N. Ferraro, Charles P. O'Brien, Wade H. Berrettini
Thomas Ferraro